Stock Taper
Solventum Corporation, founded in 2023 in Saint Paul, MN, develops and markets healthcare solutions across Medsurg, Dental, Health Information Systems, and Purification/Filtration segments to meet critical patient and customer needs.

Solventum's engineered synthetic scaffold supports natural healing of complex wounds, reflecting its strategic focus on leading innovation in the wound care market.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Product | $1.59B | $1.49B ▼ | — | — |
![]() | MedSurg Segment | — | — | $1.23B | $1.37B ▲ |
![]() | Dental Solutions Segment | — | — | $354M | $396M ▲ |
![]() | Health Information Systems Segment | — | — | $342M | $354M ▲ |
| Map | REGION | Q1-2026 | Q2-2026 |
|---|---|---|---|
![]() | MedSurg Segment | $1.93B | $2.12B ▲ |
Overall rating: A-
| PEER | PRICE | |
|---|---|---|
RVTY | $128.12 | COMPARE |
ICLR | $165.06 | COMPARE |
EHC | $120.97 | COMPARE |
ELAN | $23.87 | COMPARE |
ALGN | $158.80 | COMPARE |
UHS | $172.12 | COMPARE |
RDY | $12.16 | COMPARE |
ENSG | $171.37 | COMPARE |